🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As an IMG who went through the process recently, I know how nerve-wracking this can be. Thank you Mark D. Siegel and Yale Internal Medicine for instilling hope in IMGs and making the American dream alive in each and every one of us! #togethertowardsbetterAmericanhealth

Thrilled to share our latest 📜 on racial and ethnic disparities in TMVR published in JAHA Black and Hispanic patients were underrepresented in #TMVR despite similar clinical outcomes compared to White patients. ahajournals.org/doi/10.1161/JA…

While a study led the FDA to approve #TMB as a #biomarker for #immunotherapy, research from Amin Nassar, MD shows that >95% of the participants were white. So how does this biomarker perform in patients who are non-white? ⬇️⬇️ yalecancercenter.org/news-article/d… Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp

1/10. After our oral presentation at #GU23, we are excited to share our Lancet preprint on ICIs for penile cancer! Work co-led w/ Amin Nassar, MD & supervised by Guru P. Sonpavde, MD Andrea Apolo, M.D.. A global study from Global Society of Rare GU Tumors! Andrea Necchi Philippe spiess Toni Choueiri, MD papers.ssrn.com/sol3/papers.cf…

So fortunate to share our The Lancet preprint. This is proof-of-concept showing that unanswered clinical questions in rare diseases can be accomplished by global collaboration across tens of centers! TOOK A VILLAGE to answer this and hopefully more similar efforts to come.

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis: JACC Journals 1/ This is great: Primary prevention in older adults >75 years of age 2/ Moderate intensity + ezetimibe is probably better tolerated Here is 10-point summary

⁦Abdullah Al-Abcha⁩ presenting his work on staging MAC disease according to extra-mitral Cardiac damage at #TVT2023. MAC pts with more advanced MAC stages have higher mortality. Congratulations! ⁦Mayo Clinic CV⁩ ⁦Mayo Clinic Rochester Cardiology Fellows⁩

Today we share in JNCI the final results of our experience on ICI use for penile cancer. Work presented at ASCO #GU23. Thankful to co-first author Amin Nassar, MD, co-senior authors Guru P. Sonpavde, MD Andrea Apolo, M.D., colleagues, and patients from across the 🌎! academic.oup.com/jnci/advance-a…

🔥 This one is for the record! | State of the art review: AMVP and MAD: pathophysiology, risk stratification and management. 🗞️European Heart Journal — European Society of Cardiology News | IF 35.9 🖇️academic.oup.com/eurheartj/adva… 🚀 @mayoclinic | @cardioxclinic | The Sheba Medical Center at Tel Hashomer

TAVI in patients with cardiogenic shock. Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock academic.oup.com/eurheartj/arti…

Low dose amiodarone analysis academic.oup.com/eurheartj/arti… #CardioTwitter

Although immune checkpoint inhibitors demonstrate modest activity in cardiac soft tissue sarcomas, durable benefit was observed in a subset of patients w/ nonangiosarcoma, albeit w/ higher toxicity. bit.ly/3OvJiYD #JACCCardioOnc #CardioOnc #Immunotherapy Amin Nassar, MD

🫀Don't miss this original research from a great team in JACC Journals! 📰tinyurl.com/bu4kxxnf Amin Nassar, MD Toni Choueiri, MD george demetri Tomas G. Neilan, MD, MPH Aakash Desai, MD, MPH, FASCO Hanna Dalla Pria, MD Ryan Denu, MD, PhD #JACCCardioOnc

🚨 It’s all about that Right Ventricle 🚨 Excited to share our latest paper with Taha Hatab Sachin Goel in JAHA. Our work explores the prognostic value of RV afterload in patients undergoing M-TEER. Invasive evaluation of the RV is 🔑 in identifying patients at highest

‼️Check out our #JACCINT manuscript demonstrating the #prognostic implications☠️ of #cardiac_damage🫀 in patients with #MAC and mitral valve dysfunction #MVD jacc.org/doi/10.1016/j.… Tremendously grateful to Mayra Guerrero, MD ‘s mentorship🙏🏽 1/n👇🏽 JACC Journals #CardioTwitter

Awesome work in JACC Journals on sub clinical AFib! The days of everyone gets AC seem to be dissipating. We’re finally starting to narrow treatment groups, hopefully benefits to pts soon jacc.org/doi/10.1016/j.…

Delighted to share "Precision Medicine Strategies for Monitoring Treatment Response and Testing MRD in NSCLC" | VuMedi vumedi.com/video/precisio… via @vumedi

How should pulmonary #hypertension (PH) inform degenerative mitral regurgitation (MR) management? #JACCIMG provides new PH thresholds for impact on mortality in #cvVHD MR. bit.ly/3BIQyN5 #vhdMR Maurice Sarano Benjamin Essayagh, MD, FESC

New in Circulation #ahajournals, late-breaker at #ACC25 American College of Cardiology E-alerts to providers improved early recognition, referral, AVR rates, and survival for patients with severe & symptomatic AS in a clinical trial Mass General Brigham Sammy Elmariah MD MPH ahajrnls.org/3QVW0k4

Introducing Curvia — a global mentorship platform connecting ambitious students with top-tier researchers to unlock their full potential. 💡 Get published. 🧬 Learn research from the ground up. 🌍 Build your future with dedicated mentors. 🔗 curvia.org |